Market cap
₹7 Cr
Revenue (TTM)
₹-- Cr
P/E Ratio
--
P/B Ratio
0.2
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -26.92 | -35.96 | -39.21 | -74.96 | -56.14 |
| EBIT | -50.00 | -50.00 | -75.00 | -58.89 | -41.48 |
| Net Profit | -50.00 | -50.00 | -66.96 | -59.28 | -44.71 |
| EPS | -60.00 | -60.00 | -66.67 | -359.43 | -44.55 |
| Book Value | -- | -- | -29.14 | -40.74 | -26.88 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-19 | Mar-18 | Mar-17 |
| EBIT-Margin
| -1,572.23 | -780.91 | -- | -3,149.43 | 4.98 |
| Net Margin
| -651.46 | -319.23 | -- | -1,307.33 | 4.41 |
| Return on equity
| -30.66 | -18.18 | -34.08 | -58.01 | 0.11 |
| Return on Capital
| -28.71 | -16.91 | -34.32 | -51.97 | 0.16 |
| Return on Assets
| -28.57 | -16.93 | -30.36 | -55.45 | 0.11 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.00 | 0.00 |
Profitability
ROCE
-34.32
Lower than Peers by 49.78
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
-34.32
|
-51.97
|
0.16
|
1.04
|
0.56
|
|
Peer Median
|
15.46
|
15.21
|
--
|
--
|
--
|
ROE
-34.08
Lower than Peers by 47.05
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
-34.08
|
-58.01
|
0.11
|
0.49
|
0.57
|
|
Peer Median
|
12.97
|
9.89
|
--
|
--
|
--
|
ROA
-30.36
Lower than Peers by 36.36
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
-30.36
|
-55.45
|
0.11
|
0.49
|
0.56
|
|
Peer Median
|
5.99
|
5.28
|
--
|
--
|
--
|
EBIT Margin
--
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
--
|
-3,149.43
|
4.98
|
13.88
|
6.92
|
|
Peer Median
|
14.56
|
14.68
|
--
|
--
|
--
|
Net Margin
-9,573.48
Lower than Peers by 9,583.87
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
-9,573.48
|
-1,307.33
|
4.41
|
14.41
|
11.59
|
|
Peer Median
|
10.39
|
9.44
|
--
|
--
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
--
|
--
|
24.99
|
37.81
|
33.04
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-100.00
Lower than Peers by 111.25
Year on year growth in net sales
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
-100.00
|
-91.61
|
-30.69
|
-40.45
|
34.72
|
|
Peer Median
|
11.25
|
8.37
|
--
|
--
|
--
|
EBIT Growth
61.94
Higher than Peers by 33.63
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
61.94
|
-5,406.42
|
-75.13
|
19.46
|
757.16
|
|
Peer Median
|
28.31
|
22.09
|
--
|
--
|
--
|
Net Profit Growth
64.37
Higher than Peers by 39.87
Year on year growth in profit after tax
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
64.37
|
--
|
-82.62
|
-12.90
|
18.07
|
|
Peer Median
|
24.50
|
9.35
|
--
|
--
|
--
|
EPS Growth
64.38
Higher than Peers by 39.87
Year on year growth in earnings per share
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
64.38
|
--
|
-82.59
|
-13.33
|
19.05
|
|
Peer Median
|
24.50
|
5.26
|
--
|
--
|
--
|
Book Value Growth
-29.12
--
Year on year growth in book value per share
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
-29.12
|
-44.97
|
-46.63
|
0.49
|
-0.08
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.29
|
0.29
|
--
|
--
|
--
|
Current Ratio
1.27
Lower than Peers by 0.52
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
1.27
|
1.33
|
11.20
|
3.96
|
3.93
|
|
Peer Median
|
1.79
|
1.68
|
--
|
--
|
--
|
Quick Ratio
1.27
Lower than Peers by 0.12
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
1.27
|
1.33
|
6.95
|
3.96
|
3.93
|
|
Peer Median
|
1.39
|
1.25
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
--
|
--
|
--
|
7,111.72
|
3,663.36
|
|
Peer Median
|
13.34
|
10.92
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
--
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
--
|
1,324.39
|
111.16
|
77.04
|
33.16
|
|
Peer Median
|
19.56
|
23.15
|
--
|
--
|
--
|
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
--
|
0.00
|
0.02
|
0.03
|
0.05
|
|
Peer Median
|
0.69
|
0.73
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
--
|
4,834.04
|
405.72
|
242.21
|
1,007.28
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
--
|
--
|
460.26
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
--
|
--
|
265.08
|
29.23
|
25.33
|
|
Peer Median
|
23.97
|
31.85
|
--
|
--
|
--
|
Price / Book Value
--
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
--
|
--
|
0.42
|
0.14
|
0.14
|
|
Peer Median
|
2.47
|
2.93
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.79
|
0.56
|
--
|
--
|
--
|
EV/EBITDA
-41.99
Lower than Peers by 63.96
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
-41.99
|
-24.55
|
43.91
|
8.86
|
9.17
|
|
Peer Median
|
21.97
|
23.55
|
--
|
--
|
--
|
Market Cap
--
--
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-19
|
Mar-18
|
Mar-17
|
Mar-16
|
Mar-15
|
|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
--
|
--
|
7
|
4
|
4
|
|
Peer Median
|
8,549
|
10,579
|
--
|
--
|
--
|